Healthcare, Pharmaceuticals and Biotech
Kroll Life Sciences Webcast Series
Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships. Kroll recently brought together our leading experts and industry leaders to share insights and trends on valuation, technology, intellectual property (IP), risk and regulation in a life sciences webcast series.
Kroll helps organizations in the healthcare, pharmaceuticals and biotechnology sectors address complex business challenges related to governance, risk and transparency.
Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships.
Underpinning these dynamics is the uncertainty created by a post-COVID-19 environment. The implications have been far-reaching and will likely impact the entire life science ecosystem. While companies need to be aware of the risks to their organization, Kroll understands the complexity of these challenges and works with clients worldwide to drive progress, navigate new opportunities and manage risk.
Our life sciences specialists bring practical, in-depth experience to healthcare and life sciences companies, including consumer health, medical devices, diagnostics and pharmaceuticals. We help our clients address their most pressing challenges in in the areas of valuation, expert services, investigations, cyber risk, corporate finance, security, restructuring, legal and business solutions, data analytics, due diligence and regulatory compliance.
Kroll recently spoke with intellectual property expert Alexandra Pygall, a partner at Stephenson Harwood LLP, on patent waivers for the COVID-19 vaccines. Watch this short video to learn more about how patent waivers play a role in the global distribution of vaccines and what it can mean for the future of the healthcare and pharmaceutical industries.
Valuation Advisory Services
Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.
Healthcare expertise for middle-market M&A transactions.
Forensic Investigations and Intelligence
Providing clients with global investigative expertise to help make critical decisions and mitigate risk.
Incident response, digital forensics, breach notification, managed detection services, penetration testing, cyber assessments and advisory.
Security Risk Management
Helping clients anticipate/respond to a myriad of facility, operational and employee security challenges.
Compliance Risk and Diligence
Complying with anti-money laundering and anti-bribery and corruption regulations.
Financial Services Compliance and Regulation
Local and global compliance expertise for the financial services industry.
Transaction Advisory Services
Seamless analytical advisory through the deal continuum, from transaction origination to closing.
Built upon the foundation of its renowned valuation business, Kroll's Tax Service practice follows a detailed and responsive approach to capturing value for clients.
Independent expert analysis, testimony, advice and investigations for complex disputes and projects.
Life Sciences Webcast Series
A Panel of Experts Discusses Navigating Price Gouging Rules
Operational Risk Trends in Life Sciences
Protection of Vaccine Supply Chain
Kroll Unifies Brand to Reflect Strategic Growth and Vision
Kroll Appoints David Lewis, Former Executive Secretary of the FATF, as a Managing Director to Lead its AML Advisory Practice
Who’s Who Legal Recognizes Six Kroll Professionals in the Fields of Financial Restructuring and Insolvency Worldwide
Kroll Expands Cloud Security and Red Team Capabilities with Acquisition of Security Compass Advisory